Research programme: HIV therapy - Oregon Health and Science University/Virogenomics
Latest Information Update: 26 Mar 2007
At a glance
- Originator Oregon Health & Science University; Virogenomics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 03 Jun 2003 Preclinical trials in HIV infections treatment in USA (unspecified route)